drugset / Trial / NCT00002374

A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients

NCT00002374

Phase 3 Completed 120 enrolled Hoffmann-La Roche
Treatment

Summary

To examine the efficacy of saquinavir SGC (soft gel capsules) in combination with other antiretrovirals in HIV-1 infected patients currently treated with saquinavir HGC (hard gel capsules) measured by the absolute change in plasma HIV-1 RNA during the 24 weeks of study treatment.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Nelfinavir Other / unclassified
Subject Ritonavir Other / unclassified
Subject Saquinavir Small molecule
Subject Stavudine Other / unclassified